Page last updated: 2024-09-04

conivaptan and nelfinavir

conivaptan has been researched along with nelfinavir in 1 studies

Compound Research Comparison

Studies
(conivaptan)
Trials
(conivaptan)
Recent Studies (post-2010)
(conivaptan)
Studies
(nelfinavir)
Trials
(nelfinavir)
Recent Studies (post-2010) (nelfinavir)
18817641,240230240

Protein Interaction Comparison

ProteinTaxonomyconivaptan (IC50)nelfinavir (IC50)
Tyrosine-protein kinase FynHomo sapiens (human)7.971
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)8.852
ATP-dependent translocase ABCB1Homo sapiens (human)3.3938
Cytochrome P450 3A4Homo sapiens (human)1.275
ATP-dependent translocase ABCB1Mus musculus (house mouse)2.3
Sodium-dependent noradrenaline transporter Homo sapiens (human)8.852
Protease Human immunodeficiency virus 10.53
Protease Human immunodeficiency virus 10.0054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for conivaptan and nelfinavir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016